Revolution Medicines (RVMD) Proxy filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for June 18, 2026, at 7:30 a.m. PDT via virtual platform.

• Proxy materials, including the Notice, Proxy Statement, and Annual Report, are available online for review and voting.

• Proxies may be submitted via internet, phone, or mail, with instructions provided for each method.

Voting matters and shareholder proposals

• Election of two Class I directors to serve until the 2029 Annual Meeting or until successors are elected.

• Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote to approve executive compensation (Say-on-Pay) as disclosed in the Proxy Statement.

• Proxies are authorized to transact other business as may properly come before the meeting.

Board of directors and corporate governance

• Director nominees for election are Alexis Borisy and Mark A. Goldsmith, MD, Ph.D.

• Board of Directors recommends voting FOR all proposals presented.